
|Poll|February 27, 2023
Poll results: How comfortable are you with including biosimilars in your treatment plans?
Author(s)Kassi Filkins, Editor
See the results from our recent poll!
Advertisement
Optometry Times asked our audience, "How comfortable are you with including biosimilars in your treatment plans?" and the results are in!
The poll appeared on OptometryTimes.com and was promoted across social channels from Feb. 15 to Feb. 22, 2023.
10 ODs responded:
- 4 said, "Very excited to begin embracing biosimilars"
- 4 said, "Feeling comfortable exploring biosimilar options, though cautiously"
- 0 said, "Still hesitant, I need to learn more about biosimilars"
- 2 said, "With the knowledge of biosimilars I have, I am not comfortable including this in my treatment plans"
To learn more about biosimilars for AMD, check out Euin Cheong, OD's piece on "
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
3D-printed contact lenses offer patient-specific fit in 20 minutes
2
First patient enrolled in pilot cataract trial assessing lanosterol eye drop ZOC2017217
3
Atropine, aspherical lenses enter trial for childhood myopia
4
The influence of the gut microbiome on eye health
5




















